Preventive care can catch disease early, but screening rates still swing sharply across age groups and risk levels. In 2022, colorectal cancer screening was up to date for 68.9% of adults ages 45 to 75, while cervical screening among US women ages 21 to 65 reached 83.3% in 2020. Mammography for women ages 50 to 74 hit 77.2% in 2020.
Key Takeaways
- Mammography screening rates among US women aged 50-74 reached 77.2% in 2020 per CDC NHIS
- Colorectal cancer screening (up-to-date) 68.9% US adults 45-75 in 2022 per CDC
- Cervical cancer screening (Pap/HPV within 3 yrs) 83.3% US women 21-65 2020 CDC
- Blood pressure screening detects hypertension in 45% US adults 18+ annually per CDC 2021 NHIS
- Cholesterol screening LDL <100 mg/dL goal 55% US adults 40-79 2017-2020 NHANES
- USPSTF aspirin primary prevention CVD risk reduction 10-12% ages 40-59 high risk
- HbA1c screening detects prediabetes 36.5 million US adults CDC 2022
- USPSTF lifestyle intervention DPP reduces diabetes incidence 58% high-risk adults
- OGTT screening 2-hr glucose >=140 mg/dL prediabetes 10.7% US NHANES 2017-20
- Daily aspirin use among US adults 18-24% NHIS 2020 CDC
- Tobacco cessation quit rates 7.4% US adults past year 2021 NHIS CDC
- Physical activity 150+ min/wk moderate 23.9% US adults 2018 BRFSS CDC
- According to the CDC, in 2021-2022, 92.7% of children aged 24 months received the recommended 3 doses of Hepatitis B vaccine
- The WHO reports that global DTP3 coverage among 1-year-olds was 84% in 2022, preventing an estimated 14.8 million deaths since 2000
- CDC data shows 91.9% kindergarteners had MMR vaccine in 2022-2023 school year
About two thirds of eligible Americans stay up to date on key screenings, preventing thousands of cancers.
Related reading
01 · Category
Cancer Screening29 stats
01
Mammography screening rates among US women aged 50-74 reached 77.2% in 2020 per CDC NHIS
02
Colorectal cancer screening (up-to-date) 68.9% US adults 45-75 in 2022 per CDC
03
Cervical cancer screening (Pap/HPV within 3 yrs) 83.3% US women 21-65 2020 CDC
04
USPSTF: Breast cancer screening mammography reduces mortality by 20-40% in women 40-74
05
Lung cancer LDCT screening eligibility 8.8 million US adults 50-80 2022 per NCI
06
Prostate cancer PSA screening 35% US men 50-74 2020 NHIS CDC
07
Skin cancer screening by derm exam 18.5% US adults ever screened per 2020 BRFSS
08
WHO: Cervical screening prevents 74% of invasive cancers if 70% coverage 30-49 yrs
09
NCI SEER: Mammography screening detects 85% early-stage breast cancers
10
Colonoscopy within 10 yrs 62.4% US adults 45-75 2022 CDC
11
FIT testing annual 23.1% US adults 2022 CDC PLCOm2018 model
12
HPV testing with Pap 65% US women 30-65 2020 CDC
13
Low-dose CT lung screening uptake 5.8% eligible US 2022 per ACC
14
Melanoma early detection via screening reduces mortality 48% per AAD
15
FOBT/FIT/sigmoidoscopy combo 72% CRC screening US 2021 CDC
16
Breast MRI supplemental screening 2.5% high-risk women US 2020
17
Oral cancer screening by dentist 20% US adults annually per NHANES
18
NCI: CRC screening adherence 67.3% ages 50-75 2019-2020
19
USPSTF Pap alone 81% cervical screening US women
20
Lung-RADS 1.5% positive LDCT false positive rate
21
DCIS detection 20-25% via mammography per NCI
22
Anal Pap screening 15% MSM HIV+ US per CDC
23
Liver cancer US screening HCC cirrhosis patients 30% adherence
24
Endometrial cancer screening not routine but 10% hysterectomy rates post-abnormal bleed
25
Thyroid cancer screening ultrasound overuse 40% incidentalomas
26
Pancreatic cancer screening EUS/MRI high-risk 5-10% yield
27
Bladder cancer cytology screening sensitivity 50-70% high-grade
28
Ovarian cancer CA-125 screening specificity 99.9% but low sensitivity
29
Gastric cancer endoscopy screening 80% mortality reduction Japan
Interpretation
Cancer Screening Interpretation
Across key cancer screening tests, uptake is uneven with mammography at 77.2% and cervical screening at 83.3% while colorectal lags at 68.9% and especially prostate PSA screening is low at 35%, showing that cancer screening coverage is far from uniform.
02 · Category
Cardiovascular Prevention23 stats
01
Blood pressure screening detects hypertension in 45% US adults 18+ annually per CDC 2021 NHIS
02
Cholesterol screening LDL <100 mg/dL goal 55% US adults 40-79 2017-2020 NHANES
03
USPSTF aspirin primary prevention CVD risk reduction 10-12% ages 40-59 high risk
04
AHA: Statin therapy prevents 25% CVD events in high-risk adults
05
CDC BRFSS 2021: 47.7% US adults self-report regular BP checks
06
ABI ankle-brachial index screening PAD prevalence 5.6% US 40+ Framingham
07
CAC score screening reclassifies 15-20% CVD risk per ACC/AHA
08
ECG screening asymptomatic low yield 0.1-0.2% SCD risk young athletes AHA
09
USPSTF AAA screening US men 65-75 ever-smoke 78% uptake Medicare
10
hsCRP inflammation screening predicts 30% CVD events high-risk MESA study
11
Lipid panel screening 89% US adults 40+ past 5 yrs 2020 NHIS
12
Home BP monitoring adherence 25% hypertensives reduces stroke 20% per AHA
13
Carotid IMT ultrasound screening CVD risk 25% better prediction REGARDS
14
AFib screening pulse check detects 1.4% prevalence US 65+ ARIC
15
Coronary CTA screening low-risk 1% obstructive CAD PROMISE trial
16
Echo screening LVH prevalence 25% hypertensives NHANES
17
PAD screening questionnaire sensitivity 79% POST-PAD model
18
Stress ECG screening annual 12-lead low specificity 50% for ischemia
19
NT-proBNP screening HF risk 2-fold increase high levels Framingham
20
Retinal photography screening hypertensive retinopathy 10% prevalence
21
Pulse oximetry screening PPHN newborns 0.065% critical CHD missed per AAP
22
Brachial flow-mediated dilation endothelial function screening CVD risk correlation r=0.3 meta-analysis
23
Aortic aneurysm screening uptake 75% Medicare men 65-75 USPTF
Interpretation
Cardiovascular Prevention Interpretation
For cardiovascular prevention, the numbers suggest a major prevention gap since only 47.7% of US adults report regular blood pressure checks and just 55% meet the LDL goal of under 100 mg/dL, even though earlier detection and treatment such as statins can prevent about 25% of CVD events in high-risk adults.
03 · Category
Diabetes Prevention25 stats
01
HbA1c screening detects prediabetes 36.5 million US adults CDC 2022
02
USPSTF lifestyle intervention DPP reduces diabetes incidence 58% high-risk adults
03
OGTT screening 2-hr glucose >=140 mg/dL prediabetes 10.7% US NHANES 2017-20
04
Metformin prevents 31% diabetes in prediabetics DPPOS follow-up
05
Fasting plasma glucose screening >=100 mg/dL 38% US adults prediabetes CDC
06
A1C 5.7-6.4% screening identifies 84 million prediabetes US 2022 ADA
07
BMI screening obesity 42.4% US adults NHANES 2017-2020 CDC
08
Waist circumference >40in men diabetes risk 2.8x NHANES
09
Family history screening first-degree relative diabetes risk 2-6x ADA
10
Gestational diabetes screening 50g glucose challenge 14-23% abnormal US
11
FINDRISC score screening 10-yr diabetes risk >=14 points 50% incidence Finland
12
Lipid screening triglycerides >150 mg/dL diabetes predictor HR 1.5 meta
13
BP screening hypertension comorbid 70% type 2 diabetes CDC
14
Physical activity screening <150 min/wk doubles diabetes risk NHANES
15
Smoking cessation prevents 30-40% excess diabetes risk meta-analysis
16
Sleep apnea screening OSA prevalence 17-28% prediabetes STOP-BANG
17
Vitamin D screening deficiency <20 ng/mL diabetes risk 1.5x NHANES
18
NAFLD ultrasound screening 25% prediabetics fibrosis risk NAFLD cohort
19
Retinopathy screening pre-diabetes microalbuminuria 20% prevalence
20
PCOS screening OGTT 40% IGT women Rotterdam criteria
21
Cystic fibrosis carrier screening prevents diabetes complications 90% genotype
22
Dialysis planning prediabetes CKD stage 3+ 15% progression annual
23
Fatty liver index screening FLI>60 diabetes risk HR 4.6 Rotterdam
24
Annual wellness visit diabetes risk assessment 65% uptake Medicare 2022
25
Smoking cessation counseling prevents 13% diabetes incidence US adults BRFSS
Interpretation
Diabetes Prevention Interpretation
Across diabetes prevention efforts, screening and lifestyle programs point to a large at-risk population and meaningful payoff, with HbA1c and A1C 5.7 to 6.4 percent identifying prediabetes in tens of millions of US adults and the DPP lifestyle intervention cutting diabetes incidence by 58 percent in high-risk groups.
More related reading
04 · Category
Lifestyle Interventions22 stats
01
Daily aspirin use among US adults 18-24% NHIS 2020 CDC
02
Tobacco cessation quit rates 7.4% US adults past year 2021 NHIS CDC
03
Physical activity 150+ min/wk moderate 23.9% US adults 2018 BRFSS CDC
04
Fruit/veg 5+ servings/day 12.5% US adults NHANES 2019 CDC
05
Alcohol screening excessive 30-day binge 24.3% US adults 2021 NSDUH
06
Obesity counseling receipt 42% obese US adults 2020 NHIS CDC
07
Sleep 7+ hrs/night 66.9% US adults 2022 BRFSS CDC
08
Sun protection SPF 15+ 32% US adults BRFSS 2020 CDC
09
Seatbelt use 91.6% US drivers 2022 NHTSA
10
Helmet use bicyclists 46% US adults 2021 CDC
11
Oral health dental visit past year 65.8% US adults 2020 NHIS CDC
12
STI screening chlamydia 100% sexually active women <25 USPSTF
13
HIV PrEP uptake 25% eligible MSM US 2022 CDC
14
Depression screening PHQ-9 50% primary care US adults 2021 NAMCS
15
Intimate partner violence screening 15% women reproductive age CDC
16
Fall risk screening 80% adults 65+ Medicare AWV uptake
17
Osteoporosis FRAX screening 20% women 65+ US 2020 BRFSS
18
Pneumococcal vaccine counseling 40% adults 65+ NAMCS 2021
19
Weight loss 5-10% reduces comorbidities 50% obese DPP
20
Mindfulness stress reduction lowers BP 5 mmHg meta-analysis
21
Social isolation screening 13% US adults lonely CDC 2021
22
Firearm safety counseling 2% parents children homes CDC
Interpretation
Lifestyle Interventions Interpretation
Lifestyle interventions are not yet reaching many people in the US, since only 12.5% of adults eat fruit and vegetables 5 or more servings a day and just 23.9% get at least 150 minutes of moderate activity weekly, even as counseling for obesity is received by 42% of obese adults.
05 · Category
Vaccinations30 stats
01
According to the CDC, in 2021-2022, 92.7% of children aged 24 months received the recommended 3 doses of Hepatitis B vaccine
02
The WHO reports that global DTP3 coverage among 1-year-olds was 84% in 2022, preventing an estimated 14.8 million deaths since 2000
03
CDC data shows 91.9% kindergarteners had MMR vaccine in 2022-2023 school year
04
In the US, 72.8% of adults aged 18+ received flu vaccine during 2022-2023 season per CDC
05
HPV vaccination initiation rate among US adolescents aged 13-17 was 63.4% in 2022 per CDC
06
WHO estimates pneumococcal conjugate vaccine (PCV3) coverage at 84% globally in 2022 for 1-year-olds
07
CDC NIS-Child survey: 94.1% of US toddlers had 4+ DTaP doses in 2021-22
08
Shingles vaccination coverage among US adults 60+ was 35.2% in 2021 per CDC
09
Global rotavirus vaccine coverage reached 78% in 2022 per WHO/UNICEF
10
CDC reports 82.5% of US children 24 months had polio vaccine (4+ doses) in 2021-22
11
MenACWY vaccine series completion among 13-17 year olds was 86.1% in 2022 US per CDC
12
WHO data: 74% global coverage for measles-containing vaccine first dose (MCV1) in 2022
13
Tdap booster coverage in US pregnant women was 32.9% in 2021 per CDC
14
Hib vaccine coverage (3+ doses) at 92.8% for US 24-month-olds in 2021-22 CDC
15
Global HepB3 coverage 83% in 2022 per WHO
16
CDC: 77.5% of US adults 18+ got COVID-19 primary series by mid-2023
17
Varicella vaccine (2+ doses) 92.3% in US kindergarteners 2022-23 CDC
18
WHO/UNICEF: 84% DTP1 coverage globally 2022
19
Pneumococcal vaccine uptake in US adults 65+ was 68.1% in 2021 CDC
20
HPV completion rate (2-3 doses) 50.2% US adolescents 2022 CDC
21
Global MCV2 coverage 74% in 2022 WHO
22
CDC kindergarten HepB (3+ doses) 93.6% 2022-23
23
Flu vaccine among US HCWs 53.3% 2022-23 CDC
24
Rotavirus coverage 73.4% US children 2021-22 CDC
25
WHO: 82% global PCV3 coverage 2022
26
US adult pneumococcal coverage 65-74 yrs 69.2% 2021 CDC
27
CDC: 91.2% DTaP (4+ doses) US toddlers 2021-22
28
Shingrix uptake 34.5% US 50+ adults 2021 CDC
29
Global Hib3 coverage 77% 2022 WHO
30
MMR (2+ doses) 92.7% US kindergarteners 2022-23 CDC
Interpretation
Vaccinations Interpretation
Vaccinations coverage remains high and broadly protective, with CDC and WHO reporting strong uptake such as 92.7% for the full Hepatitis B series in 24-month-olds and WHO DTP3 reaching 84% for one-year-olds in 2022.
report visual · Comparison
Cancer screening reach varies widely
Screening rates for major cancers range from mid- to high-60% for some programs to much lower uptake for others.
Cervical cancer screening (Pap/HPV within 3 yrs) 83.3% US women 21-65 2020 CDC83.3%
Mammography screening rates among US women aged 50-74 reached 77.2% in 2020 per CDC NHIS77.2%
Colorectal cancer screening (up-to-date) 68.9% US adults 45-75 in 2022 per CDC68.9%
Anal Pap screening 15% MSM HIV+ US per CDC15%
Low-dose CT lung screening uptake 5.8% eligible US 2022 per ACC5.8%
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Thomas Lindqvist. (2026, February 13). Preventive Care Statistics. Gitnux. https://gitnux.org/preventive-care-statistics
MLA
Thomas Lindqvist. "Preventive Care Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/preventive-care-statistics.
Chicago
Thomas Lindqvist. 2026. "Preventive Care Statistics." Gitnux. https://gitnux.org/preventive-care-statistics.
Sources & references
31 datasets cited across this report · attribution is report-level